Barely Significant
← all excerpts

Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons.

Hematol Rep · 2023 · PMC10743216 · PMID 38132276

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
As expected, in the overall analysis of these eight trials, the between-trial heterogeneity was highly significant (concordance = 0.687 with standard error = 0.019; likelihood ratio test = 97.96 on 2 df, p < 0.001; Wald test = 40.92 on 2 df, p < 0.001). 4.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.